Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q415392> ?p ?o }
- Q415392 subject Q7211373.
- Q415392 subject Q8790412.
- Q415392 abstract "Omalizumab, sold under the trade name Xolair, is a humanized antibody originally designed to reduce sensitivity to inhaled or ingested allergens, especially in the control of moderate to severe allergic asthma, which does not respond to high doses of corticosteroids. It has been approved for treating adult and adolescent patients 12 years and older with severe or moderate to severe allergic asthma in more than 90 countries, since its first of such approval in 2002 in Australia. Omalizumab was approved in March 2014 in the European Union and the U.S.A. and in about 10 other countries for treating patients 12 years and above with chronic spontaneous urticaria (CSU) (also referred to as chronic idiopathic urticaria or CIU), which cannot be treated with H1-antihistamines. CSU is not an allergic disease. Presently, the drug is being actively studied in clinical trials for various allergic diseases and some non-allergic diseases, especially skin diseases.Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. Unlike an ordinary anti-IgE antibody, it does not bind to IgE that is already bound by the high affinity IgE receptor (FcεRI) on the surface of mast cells, basophils, and antigen-presenting dendritic cells.IgE is commonly involved in type I hypersensitivity, which manifests the most prevalent allergic diseases. It has been estimated that as high as 20 to 40% of the populations who live a western lifestyle in economically advanced countries are affected by allergy and seek medical help. In the U.S., 8% of adults and 10% of children have asthma. Allergy occurs more frequently in individuals with higher serum IgE levels, though some allergic individuals have very low serum IgE, and some people with very high IgE have no allergic problems.".
- Q415392 atcPrefix "R03".
- Q415392 atcSuffix "DX05".
- Q415392 casNumber "242138-07-4".
- Q415392 drugbank "DB00043".
- Q415392 fdaUniiCode "2P471X1Z11".
- Q415392 wikiPageExternalLink omalgen062003LB.pdf.
- Q415392 wikiPageExternalLink www.xolair.com.
- Q415392 wikiPageExternalLink www.asthmamatters.com.
- Q415392 wikiPageWikiLink Q1004647.
- Q415392 wikiPageWikiLink Q1075697.
- Q415392 wikiPageWikiLink Q107988.
- Q415392 wikiPageWikiLink Q11009.
- Q415392 wikiPageWikiLink Q112670.
- Q415392 wikiPageWikiLink Q1129007.
- Q415392 wikiPageWikiLink Q12202.
- Q415392 wikiPageWikiLink Q128711.
- Q415392 wikiPageWikiLink Q1427096.
- Q415392 wikiPageWikiLink Q1430844.
- Q415392 wikiPageWikiLink Q14876567.
- Q415392 wikiPageWikiLink Q159341.
- Q415392 wikiPageWikiLink Q1616930.
- Q415392 wikiPageWikiLink Q1641412.
- Q415392 wikiPageWikiLink Q1671412.
- Q415392 wikiPageWikiLink Q168800.
- Q415392 wikiPageWikiLink Q170050.
- Q415392 wikiPageWikiLink Q1754830.
- Q415392 wikiPageWikiLink Q187440.
- Q415392 wikiPageWikiLink Q188930.
- Q415392 wikiPageWikiLink Q189082.
- Q415392 wikiPageWikiLink Q191989.
- Q415392 wikiPageWikiLink Q2035485.
- Q415392 wikiPageWikiLink Q204711.
- Q415392 wikiPageWikiLink Q2059279.
- Q415392 wikiPageWikiLink Q208467.
- Q415392 wikiPageWikiLink Q210420.
- Q415392 wikiPageWikiLink Q2106364.
- Q415392 wikiPageWikiLink Q212354.
- Q415392 wikiPageWikiLink Q244680.
- Q415392 wikiPageWikiLink Q268667.
- Q415392 wikiPageWikiLink Q272436.
- Q415392 wikiPageWikiLink Q285697.
- Q415392 wikiPageWikiLink Q3077570.
- Q415392 wikiPageWikiLink Q323936.
- Q415392 wikiPageWikiLink Q324089.
- Q415392 wikiPageWikiLink Q32811.
- Q415392 wikiPageWikiLink Q3425168.
- Q415392 wikiPageWikiLink Q35869.
- Q415392 wikiPageWikiLink Q389735.
- Q415392 wikiPageWikiLink Q390551.
- Q415392 wikiPageWikiLink Q422248.
- Q415392 wikiPageWikiLink Q424190.
- Q415392 wikiPageWikiLink Q425941.
- Q415392 wikiPageWikiLink Q4573411.
- Q415392 wikiPageWikiLink Q506253.
- Q415392 wikiPageWikiLink Q507154.
- Q415392 wikiPageWikiLink Q5133746.
- Q415392 wikiPageWikiLink Q5215707.
- Q415392 wikiPageWikiLink Q5439273.
- Q415392 wikiPageWikiLink Q56646.
- Q415392 wikiPageWikiLink Q5939625.
- Q415392 wikiPageWikiLink Q5941165.
- Q415392 wikiPageWikiLink Q6060674.
- Q415392 wikiPageWikiLink Q61233.
- Q415392 wikiPageWikiLink Q644318.
- Q415392 wikiPageWikiLink Q6501235.
- Q415392 wikiPageWikiLink Q679692.
- Q415392 wikiPageWikiLink Q6973027.
- Q415392 wikiPageWikiLink Q7157933.
- Q415392 wikiPageWikiLink Q7168.
- Q415392 wikiPageWikiLink Q7211373.
- Q415392 wikiPageWikiLink Q745130.
- Q415392 wikiPageWikiLink Q7679593.
- Q415392 wikiPageWikiLink Q7683742.
- Q415392 wikiPageWikiLink Q7817.
- Q415392 wikiPageWikiLink Q79455.
- Q415392 wikiPageWikiLink Q79848.
- Q415392 wikiPageWikiLink Q79932.
- Q415392 wikiPageWikiLink Q8055111.
- Q415392 wikiPageWikiLink Q83415.
- Q415392 wikiPageWikiLink Q864699.
- Q415392 wikiPageWikiLink Q8790412.
- Q415392 wikiPageWikiLink Q898365.
- Q415392 wikiPageWikiLink Q904140.
- Q415392 wikiPageWikiLink Q9122598.
- Q415392 wikiPageWikiLink Q918396.
- Q415392 wikiPageWikiLink Q927234.
- Q415392 atcPrefix "R03".
- Q415392 atcSuffix "DX05".
- Q415392 casNumber "242138".
- Q415392 drugbank "DB00043".
- Q415392 unii "2".
- Q415392 type ChemicalSubstance.
- Q415392 type Drug.
- Q415392 type ChemicalObject.
- Q415392 type Thing.
- Q415392 type Q8386.
- Q415392 comment "Omalizumab, sold under the trade name Xolair, is a humanized antibody originally designed to reduce sensitivity to inhaled or ingested allergens, especially in the control of moderate to severe allergic asthma, which does not respond to high doses of corticosteroids. It has been approved for treating adult and adolescent patients 12 years and older with severe or moderate to severe allergic asthma in more than 90 countries, since its first of such approval in 2002 in Australia.".